Losartan treatment is linked to aldosterone reductions in patients with hypertension but not obstructive sleep apnea.
Findings indicate high-risk adults would benefit from intensive program to lower SBP to 120 or less.
Add-on mineralocorticoid receptor antagonist therapy increased serum potassium by 0.4 mEq.
Low DBP linked to myocardial damage, CHD events especially among those with SBP 120 mm Hg.
Significantly higher nighttime systolic blood pressure, especially in patients with diabetes and low eGFR.
Black CKD patients with strict blood pressure control had a 19% lower risk of premature death.
Sleep apnea with resistant HTN linked to increased risk of ischemic heart event, congestive heart failure.
Low aerobic capacity has greater effect than even high cholesterol, high blood pressure.
Commonly used meds linked to increased risk of hospitalization for dehydration, heat-related illness.
Notable improvement seen with carvedilol and nebivolol, but not betaxolol.
Future studies are needed to assess potential benefits of hypertension screening for daytime nappers.
Researchers found a 16% lower risk for strokes, heart attacks, and death combined among patients who took ACEIs or ARBs.
Only 40% of older patients transitioning to maintenance dialysis were on renin-angiotensin system blockade.
As a heterogenous disease, obesity requires an individualized approach to treatment.
The FDA has developed 2- and 10-year goals to reduce sodium content in both processed and prepared foods.
Hypertension risk up for both short-term and long-term exposure.
One in 4 MI survivors develop heart failure within 4 years.
As elderly patients age, the number of drugs they take that may cause hyperkalemia increases.
Heart groups issue updated guideline for the treatment of heart failure.
The findings warrant reconsideration of blood pressure targets for many patients older than 75, according to an editorial.
African Americans with masked hypertension had 2 times the risk of developing clinic hypertension.
Researchers say restricting sodium might backfire, but heart experts are critical of the finding.
Odds increase with rapid rise in middle age.
Latest findings from national trial show it lowers chances of heart failure, even in older adults.
A patient's short-term fall risk increases in the 15 days after initiation or intensification of antihypertensive medication.
Elevated systolic BP is linked to adverse outcomes in elderly patients.
Treatment with angiotensin-converting enzyme inhibitors was most strongly associated with hyperkalemia.
Treatment linked to improved long-term survival, regardless of underlying kidney function.
The addition of aliskiren to enalapril led to more adverse events in patients with chronic heart failure without an increase in benefit.
More than half of high-risk atrial fibrillation patients are not prescribed oral anticoagulants.
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)